| Topic Name: |
biotech boutique consulting firms... |
| Message Name: |
clarifications |
| Date Posted: |
10/19/2003 |
| In Reply To: |
given Pharma's big outsourcing move towards contract research etc, I could see where strategy consultants could assess whether working with pharma and doing their dirty (wet) work would be more profitable, while retaining licensing rights for their own drugs etc.
But for all these, I don't entirely see how a biotech degree would be of any special use.
I know Merck has a tech strategy team that assesses the value of any potential technology acquisitions (say HT assay companies etc) and these teams have both PhDs and MBAs.
Hope you can get some useful info out of these ramblings.
cheers |
| Message: |
I meant a biotech doing pharma's wet work while retaining licensing rights to any drugs that it may develop or exclusive licensing agreements with pharma.
|
|
